Novacyt S.A.

€0.41As of Sun 8 Nov 2026, 12:00 UTC
EPA:ALNOVHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR (9.54%)
Div yield —
ROE (75.24%)
Medical Devices
Beta (5Y) 1.36
PE TTM —
TSR TTM (8.89%)
Mkt cap €29.73M
ROIC (54.70%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.423
3.15%
(64.47%)
Hold 11|9|7|11|12
4Q25
1Q26
2Q26
3Q26
Earnings per share£
—
—
—
0.01
(2.18%)
(13.01%)
(6.98%)
3.45%
Revenue£M
1.645
1.624
1.636
1.695
1.82%
(0.22%)
(0.95%)
3.91%
Peers (US$33.38M)
Cap (US$)
PE
26.43M
56.63x
24.91M
—
21.61M
—
32.93M
240.2x
Capital
TTM
5Y
10Y
Leveragex
1.400
0.435
0.447
EBIT/Intx
0.713
0.117
0.093
Own earn%
84.66
87.10
92.65
Sh yield%
37.36
44.44
46.56
Owners
Insiders/Inst%
12.76
80.96
Short interest%
1.40
SBC / revenue%
4.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
21–30
$1 testx
—
Incr. ROIC%
4